Imatinib mesylate is a targeted therapy drug used to treat Chronic myeloid leukemia, Acute lymphoblastic leukemia, Gastrointestinal stromal tumours, Hypereosinophilic syndrome, Dermatofibrosarcoma protuberans, Systemic mastocytosis, Myelodysplastic or myeloproliferative diseases.
Tag:
